Zenagamtide, a Novel, Long-Acting, Unimolecular GLP-1 and Amylin Receptor Agonist, Does Not Impact the Pharmacokinetics of the Combined Oral Contraceptive, Levonorgestrel/Ethinylestradiol
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.